The advent of the molecular world opening up for familial adenomatous polyposis and other genetically predisposed cancers has now provided us with wonderful tools to study these diseases. The challenges, however, clearly remain to transfer discoveries in the laboratory to improvements in the care of these patients.
Cites: Can Med Assoc J. 1981 Jun 1;124(11):1427-86113045
Cites: Can J Ophthalmol. 1990 Apr;25(3):159-632163281
Cites: Gen Hosp Psychiatry. 1992 Jan;14(1):61-81309713